Manufacturing News

Novartis Investing $1.25 Billion In China

Pharmaceuticals company Novartis AG said Tuesday (November 03) it will invest $1.25 billion in its research centers in China over the next five years.

The company said it will spend $1 billion expanding the Novartis Institute of BioMedical Research in Shanghai, which specializes in the research of diseases particularly prevalent in China.

Another $250 million will be invested in a new technical facility in Changshu, which researches, develops and manufactures active pharmaceutical ingredients, said Novartis.

"We are confident that our expanded investment in R&D will result in innovative therapies for patients in China and other countries nurtured by the growing scientific excellence in China," said Chief Executive Daniel Vasella.

Most Viewed in 24 Hours


Start a Digital Twin Journey from Engineering Simulation

Accenture releases survey of digital transformation

CIMC Reduces Unplanned Downtime by 30% with Greater Operational Insight from ThingWorx

Ansys Simulation Speeding up Autonomous Vehicles

  • Tel : 0086-27-87592219
  • Email :
  • Add: 3B1 International Business Center, No. 18 Jinronggang Road (No.4), East Lake High-tech Development Zone, Wuhan, Hubei, PRC. 430223
  • ICP Business License: 鄂B2-20030029-9
  • Copyright © e-works All Rights Reserved